Tag: Huang Peng
East & Concord advises in tumour-therapy licence win
China’s first commercial-use licensing of boron neutron capture therapy (BNCT) saw East & Concord Partners advising
China’s first commercial-use licensing of boron neutron capture therapy (BNCT) saw East & Concord Partners advising
Life insurers’ digital shift demands stronger legal oversight to protect customer data and cyber resilience
Follow us on LinkedIn